The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Preliminary routes focused on amino acid chain section coupling, utilizing https://arontsqi457277.dailyblogzz.com/41188658/creation-and-research-applications-of-retatrutide